共 50 条
Complement control for COVID-19
被引:19
|作者:
Bosmann, Markus
[1
,2
,3
,4
]
机构:
[1] Boston Univ, Sch Med, Dept Med, Ctr Pulm, Boston, MA 02118 USA
[2] Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, D-55131 Mainz, Germany
[3] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA
[4] Univ Med Ctr Mainz, Res Ctr Immunotherapy FZI, D-55131 Mainz, Germany
基金:
美国国家卫生研究院;
关键词:
D O I:
10.1126/sciimmunol.abj1014
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Excessive complement activation contributes to lung disease and adverse patient outcomes in COVID-19 (see the related research articles by Yan et al. and Ma et al.).
引用
收藏
页数:3
相关论文